Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of raw Pinellia ternate in treating esophageal cancer

被引:0
|
作者
Liu, Yanxin [1 ]
Bai, Yunfei [1 ]
Zhang, Jinbang [1 ]
Silva-Filho, Reginaldo [2 ]
Zhu, Qingchun [1 ]
Lei, Zhen [3 ]
机构
[1] Henan Univ Tradit Chinese Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Dept Pharm, 6 Dongfeng Rd, Zhengzhou 450053, Peoples R China
[2] Fac EBRAMEC, Sao Paulo, Brazil
[3] Henan Univ Tradit Chinese Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Cent Lab, Zhengzhou, Peoples R China
关键词
Raw Pinellia ternata (RP); esophageal cancer (EC); network pharmacology; PI3K-Akt signal pathway; PI3K/AKT SIGNALING PATHWAY; ACTIVATION; APOPTOSIS;
D O I
10.21037/jgo-23-684
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Esophageal cancer (EC) is a highly lethal malignancy with a grim prognosis and high mortality rates, primarily treated through surgery and radiotherapy. Herbal remedies are emerging as complementary approaches in cancer therapy. Here, we explore the potential therapeutic benefits of Chinese medicine raw Pinellia ternata (RP) in EC using web-based pharmacological methods and cellular experiments.Methods: The chemical components of RP were obtained by data mining via searches of the systematic pharmacology database, analysis platform, and literature on traditional Chinese medicine (TCM). The properties of the main components of RP were calculated using Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). The potential targets of the components were mined and collected through multiple databases, and the relevant potential targets of efficacy were imported into Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database to obtain protein interactions. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway enrichment analysis of the potential targets were performed through Metascape. A target-pathway network was established using Cytoscape, and topological analysis was performed on the network so as to obtain the relevant targets and pathways of RP in the treatment of EC. The inhibitory effect of RP on human EC cells was verified by cell experiments.Results: Thirteen bioactive components of RP were screened, 87 related targets were obtained by construction, and 68 co-targets were obtained after taking intersection with EC related genes. The results of the protein-protein interaction (PPI) network analysis of the targets showed that the pharmacodynamic targets of hemicellulose might be closely related to the signaling pathways such as PI3K-Akt, FOS/JUN, and HIF-1. Meanwhile, GO and KEGG enrichment analysis showed that PI3K-Akt was also significantly enriched. The in vitro cellular experiments further indicated that raw hemicrania could inhibit EC through the PI3K-Akt signaling pathway. Conclusions: The pharmacodynamic mechanism of RP in the treatment of esophageal carcinoma was preliminarily revealed, which provided ideas and the basis for further experimental study of RP in the treatment of esophageal carcinoma.
引用
收藏
页码:2006 / 2017
页数:14
相关论文
共 50 条
  • [31] Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer
    Yang, Xiaojuan
    Li, Feifei
    Shi, Youyang
    Wu, Yuanyuan
    Yang, Rui
    Liu, Xiaofei
    Zhang, Yang
    Zhang, Guangtao
    Ma, Mei
    Luo, Zhanyang
    Han, Xianghui
    Xie, Ying
    Liu, Sheng
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (05): : 763 - 775
  • [32] Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma
    Li, Xiaoliang
    Zhou, Mingyan
    Chen, Weijia
    Sun, Jiangbo
    Zhao, Yihang
    Wang, Gaoan
    Wang, Bingshu
    Pan, Yipeng
    Zhang, Junqing
    Xu, Jian
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2024, 24 (01)
  • [33] Uncovering the Mechanisms of Cinnamic Acid Treating Diabetic Nephropathy based on Network Pharmacology, Molecular Docking, and Experimental Validation
    Dai, Limiao
    He, Yang
    Zheng, Siqiang
    Tang, Jiyu
    Fu, Lanjun
    Zhao, Li
    CURRENT COMPUTER-AIDED DRUG DESIGN, 2024,
  • [34] Network Pharmacology, Molecular Docking and Molecular Dynamics to Explore the Potential Immunomodulatory Mechanisms of Deer Antler
    Liu, Lingyu
    Jiao, Yu
    Yang, Mei
    Wu, Lei
    Long, Guohui
    Hu, Wei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [35] Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification
    Chen, Jin-Fang
    Wu, Shi-Wei
    Shi, Zi-Man
    Qu, Yan-Jie
    Ding, Min-Rui
    Hu, Bing
    HEREDITAS, 2023, 160 (01)
  • [36] Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification
    Jin-Fang Chen
    Shi-Wei Wu
    Zi-Man Shi
    Yan-Jie Qu
    Min-Rui Ding
    Bing Hu
    Hereditas, 160
  • [37] Network pharmacology combined with molecular docking and experimental validation to explore the potential mechanism of Cinnamomi ramulus against ankylosing spondylitis
    Wei, Wendi
    Wu, Shaofeng
    Zhou, Chenxing
    Chen, Tianyou
    Zhu, Jichong
    Feng, Sitan
    Zhan, Xinli
    Liu, Chong
    ANNALS OF MEDICINE, 2023, 55 (02)
  • [38] Integrative approach using network pharmacology, bioinformatics, and experimental methods to explore the mechanism of cantharidin in treating colorectal cancer
    Hou, Benchao
    Wang, Xiaomin
    He, Zhijian
    Liu, Haiyun
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (09) : 6745 - 6761
  • [39] Integrated network pharmacology and experimental validation to explore the mechanisms underlying naringenin treatment of chronic wounds
    Sun, Rui
    Liu, Chunyan
    Liu, Jian
    Yin, Siyuan
    Song, Ru
    Ma, Jiaxu
    Cao, Guoqi
    Lu, Yongpan
    Zhang, Guang
    Wu, Zhenjie
    Chen, Aoyu
    Wang, Yibing
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Integrating network pharmacology, molecular docking and experimental verification to explore the therapeutic effect and potential mechanism of nomilin against triple-negative breast cancer
    Wu, Zhixuan
    Xiang, Haoyi
    Wang, Xiaowu
    Zhang, Rongrong
    Guo, Yangyang
    Qu, Liangchen
    Zhou, Jingyao
    Xiao, Yanyi
    MOLECULAR MEDICINE, 2024, 30 (01)